Antidepressant stimulation of CDP-diacylglycerol synthesis does not require monoamine reuptake inhibition

BMC Neuroscience

Volumn 11, Issue , 2010, Pages

  Aboukhatwa, Marwa A ^b   Undieh, Ashiwel S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYTIDINE DIPHOSPHATE DIGLYCERIDE; FENCLONINE; FLUOXETINE; IMIPRAMINE; MAPROTILINE; MONOAMINE; PAROXETINE; PHOSPHATIDYLINOSITIDE; SEROTONIN; SEROTONIN TRANSPORTER; BIOGENIC AMINE; CHOLINEPHOSPHOTRANSFERASE;

AMINE TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; ENZYME ACTIVITY; ENZYME INDUCTION; FOREBRAIN; HIPPOCAMPUS; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; PHOSPHOINOSITIDE METABOLISM; SEROTONIN RELEASE; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL STRAIN; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; CEREBRAL CORTEX; CYTIDINE DIPHOSPHATE DIGLYCERIDES; DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; IMIPRAMINE; MALE; MAPROTILINE; MICE; MICE, INBRED C57BL; PAROXETINE; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 76949087745     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-11-10     Document Type: Article

References (36)

1. Carlezon WA, Mague SD, Parow AM, Stoll AL, Cohen BM, Renshaw PF. Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biol Psychiatry 2005, 57:343-350. 10.1016/j.biopsych.2004.11.038, 15705349.
2. Tyeryar KR, Vongtau HO, Undieh AS. Diverse antidepressants increase CDP-diacylglycerol production and phosphatidylinositide resynthesis in depression-relevant regions of the rat brain. BMC Neurosci 2008, 9:12. 10.1186/1471-2202-9-12, 2245968, 18218113.
3. Tyeryar KR, Undie AS. Tandem regulation of phosphoinositide signaling and acute behavioral effects induced by antidepressant agents in rats. Psychopharmacology (Berl) 2007, 193:271-282. 10.1007/s00213-007-0784-1, 17435992.
4. Pandey GN, Pandey SC, Davis JM. Effect of desipramine on inositol phosphate formation and inositol phospholipids in rat brain and human platelets. Psychopharmacol Bull 1991, 27:255-261.
5. Pandey SC, Davis JM, Schwertz DW, Pandey GN. Effect of antidepressants and neuroleptics on phosphoinositide metabolism in human platelets. J Pharmacol Exp Ther 1991, 256:1010-1018.
6. Schonn JS, Desnos C, Henry JP, Darchen F. Transmitter uptake and release in PC12 cells overexpressing plasma membrane monoamine transporters. J Neurochem 2003, 84:669-677. 10.1046/j.1471-4159.2003.01561.x, 12562511.
7. Koe BK, Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther 1966, 154:499-516.
8. Kusumi I, Mikuni M, Kuroda Y, Takahashi K. Subchronic administration of para-chlorophenylalanine enhances serotonin-stimulated phosphoinositide hydrolysis in rat hippocampal slices. J Neural Transm Gen Sect 1990, 80:181-188. 10.1007/BF01245119, 2158796.
9. Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 1999, 147:162-167. 10.1007/s002130051156, 10591883.
10. Undie AS. Relationship between dopamine agonist stimulation of inositol phosphate formation and cytidine diphosphate-diacylglycerol accumulation in brain slices. Brain Res 1999, 816:286-294. 10.1016/S0006-8993(98)01076-2, 9878788.
11. Undie AS, Friedman E. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 1990, 253:987-992.
12. Claro E, Fain JN, Picatoste F. Noradrenaline stimulation unbalances the phosphoinositide cycle in rat cerebral cortical slices. J Neurochem 1993, 60:2078-2086. 10.1111/j.1471-4159.1993.tb03492.x, 8388033.
13. Stubbs EB, Agranoff BW. Lithium enhances muscarinic receptor-stimulated CDP-diacylglycerol formation in inositol-depleted SK-N-SH neuroblastoma cells. J Neurochem 1993, 60:1292-1299. 10.1111/j.1471-4159.1993.tb03289.x, 8455027.
14. Saito S, Goto K, Tonosaki A, Kondo H. Gene cloning and characterization of CDP-diacylglycerol synthase from rat brain. J Biol Chem 1997, 272:9503-9509. 10.1074/jbc.272.14.9503, 9083091.
15. Lykidis A, Jackson PD, Rock CO, Jackowski S. The role of CDP-diacylglycerol synthetase and phosphatidylinositol synthase activity levels in the regulation of cellular phosphatidylinositol content. J Biol Chem 1997, 272:33402-33409. 10.1074/jbc.272.52.33402, 9407135.
16. Saito S, Sakagami H, Tonosaki A, Kondo H. Localization of mRNAs for CDP-diacylglycerol synthase and phosphatidylinositol synthase in the brain and retina of developing and adult rats. Brain Res Dev Brain Res 1998, 110:21-30. 10.1016/S0165-3806(98)00090-X, 9733908.
17. Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nat Med 2001, 7:541-547. 10.1038/87865, 11329053.
18. Nestler EJ, Gould E, Manji H, Buncan M, Duman RS, Greshenfeld HK, et al. Preclinical models: status of basic research in depression. Biol Psychiatry 2002, 52:503-528. 10.1016/S0006-3223(02)01405-1, 12361666.
19. Morilak DA, Frazer A. Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int J Neuropsychopharmacol 2004, 7:193-218. 10.1017/S1461145704004080, 15003145.
20. Popoli M, Brunello N, Perez J, Racagni G. Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs. J Neurochem 2000, 74:21-33. 10.1046/j.1471-4159.2000.0740021.x, 10617102.
21. Tiraboschi E, Tardito D, Kasahara J, Moraschi S, Pruneri P, Gennarelli M, et al. Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology 2004, 29:1831-1840. 10.1038/sj.npp.1300488, 15138445.
22. Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 2006, 58:115-134. 10.1124/pr.58.1.7, 16507885.
23. Richardson UI, Watkins CJ, Pierre C, Ulus IH, Wurtman RJ. Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cells. Brain Res 2003, 971:161-167. 10.1016/S0006-8993(03)02333-3, 12706232.
24. Richardson UI, Wurtman RJ. Polyunsaturated fatty acids stimulate phosphatidylcholine synthesis in PC12 cells. Biochim Biophys Acta 2007, 1771:558-563. 1935022, 17350887.
25. Hostetler KY, Matsuzawa Y. Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C. Biochem Pharmacol 1981, 30:1121-1126. 10.1016/0006-2952(81)90451-2, 7259794.
26. Hurwitz R, Ferlinz K, Sandhoff K. The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. Biol Chem Hoppe Seyler 1994, 375:447-450.
27. Kucia K, Malecki A, Gabryel B, Trzeciak HI. Effect of antidepressants on the phospholipase A2 activity in plasma membranes of the rat brain cortex. Pol J Pharmacol 2003, 55:5-15.
28. Matsuzawa Y, Poorthuis BJ, Hostetler KY. Mechanism of phosphatidylinostiol stimulation of lysosomal bis (monoacylglyceryl)phosphate synthesis. J Biol Chem 1978, 253:6650-6653.
29. Xia Z, Ying G, Hansson AL, Karlsson H, Xie Y, Bergstrand A, et al. Antidepressant-induced lipidosis with special reference to tricyclic compounds. Prog Neurobiol 2000, 60:501-512. 10.1016/S0301-0082(99)00036-2, 10739086.
30. Inglis-Broadgate SL, Ocaka L, Banerjee R, Gaasenbeek M, Chapple JP, Cheetham ME, et al. Isolation and characterization of murine Cds (CDP-diacylglycerol synthase) 1 and 2. Gene 2005, 356:19-31. 10.1016/j.gene.2005.04.037, 16023307.
31. Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006, 7:137-151. 10.1038/nrn1846, 16429123.
32. Kolla N, Wei Z, Richardson JS, Li XM. Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide. J Psychiatry Neurosci 2005, 30:196-201. 1089780, 15944744.
33. Hwang J, Zheng LT, Ock J, Lee MG, Kim SH, Lee HW, et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 2008, 55:826-834. 10.1016/j.neuropharm.2008.06.045, 18639562.
34. Wille SM, Cooreman SG, Neels HM, Lambert WE. Relevant issues in the monitoring and the toxicology of antidepressants. Crit Rev Clin Lab Sci 2008, 45:25-89. 10.1080/10408360701713112, 18293180.
35. Winek CL, Wahba WW, Winek CL, Balzer TW. Drug and chemical blood-level data 2001. Forensic Sci Int 2001, 122:107-123. 10.1016/S0379-0738(01)00483-2, 11672964.
36. Devane CL, Simpkins JW, Stout SA. Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat. Psychopharmacology (Berl) 1984, 84:225-230. 10.1007/BF00427450, 6438681.